{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:19:09Z","timestamp":1787678349980,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijcard.2026.134700","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:14:24Z","timestamp":1785338064000},"page":"134700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GLIflozins in the prevention of contrast AssocIated NEphropathy: The GLICINE registry"],"prefix":"10.1016","volume":"462","author":[{"given":"Monica","family":"Verdoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Zilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Leverone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Paternoster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Faraguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Barnoffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Ciliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Dello Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Mollace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eligio","family":"Miccich\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bonmassari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rognoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ciliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijcard.2026.134700_bb0005","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2026.134700_bb0010","first-page":"S122","article-title":"Contrast-induced acute kidney injury","volume":"24","author":"Ramachandran","year":"2020","journal-title":"Indian J. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134700_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.accreview.2005.02.034","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention","volume":"14","author":"Mehran","year":"2005","journal-title":"ACC Curr. J. Rev."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134700_bb0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12882-024-03570-6","article-title":"Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment","volume":"25","author":"Li","year":"2024","journal-title":"BMC Nephrol."},{"issue":"9","key":"10.1016\/j.ijcard.2026.134700_bb0025","article-title":"The prevention and management of contrast-induced acute kidney injury: a mini-review of the literature","volume":"10","author":"Ali","year":"2018","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.ijcard.2026.134700_bb0030","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3390\/jcm13072041","article-title":"Contrast-induced acute kidney injury in patients with heart failure on sodium-glucose cotransporter-2 inhibitors undergoing radiocontrast agent invasive procedures: a propensity-matched analysis","volume":"13","author":"Nardi","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2026.134700_bb0035","doi-asserted-by":"crossref","first-page":"1307715","DOI":"10.3389\/fendo.2023.1307715","article-title":"SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis","volume":"14","author":"Meregildo-Rodriguez","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7","key":"10.1016\/j.ijcard.2026.134700_bb0040","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2026.134700_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0001-2998(86)80027-7","article-title":"ALARA and an integrated approach to radiation protection","volume":"16","author":"Hendee","year":"1986","journal-title":"Semin. Nucl. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134700_bb0050","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron. Clin. Pract."},{"key":"10.1016\/j.ijcard.2026.134700_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000498963","article-title":"The SGLT2 inhibitor empagliflozin might be a new approach for the prevention of acute kidney injury","volume":"44","author":"Chu","year":"2019","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ijcard.2026.134700_bb0060","doi-asserted-by":"crossref","first-page":"1213473","DOI":"10.3389\/fimmu.2023.1213473","article-title":"Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease","volume":"14","author":"Dai","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijcard.2026.134700_bb0065","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134700_bb0070","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134700_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2026.134700_bb0080","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ekir.2022.04.094","article-title":"Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations","volume":"7","author":"Yau","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.ijcard.2026.134700_bb0085","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134700_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134700_bb0095","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.ijcard.2026.134700_bb0100","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134700_bb0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.kint.2020.06.024","article-title":"Executive summary of the 2020 KDIGO diabetes management in CKD guideline: evidence-based advances in monitoring and treatment","volume":"98","author":"De Boer","year":"2020","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.ijcard.2026.134700_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneph.2016.159","article-title":"Acute kidney injury from SGLT2 inhibitors: potential mechanisms","volume":"12","author":"Hahn","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ijcard.2026.134700_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.918167","article-title":"Contrast-induced acute kidney injury in patients on SGLT2 inhibitors undergoing percutaneous coronary interventions: a propensity-matched analysis","volume":"9","author":"Hua","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2026.134700_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartjsupp\/suac121.499","article-title":"Role of new antidiabetic drugs in the prevention of contrast induced nephropathy in diabetic patients undergoing percutaneous coronary intervention","volume":"24","author":"Bernardini","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.ijcard.2026.134700_bb0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13098-023-01107-9","article-title":"The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study","volume":"15","author":"Feitosa","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"issue":"10315","key":"10.1016\/j.ijcard.2026.134700_bb0130","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(21)02326-6","article-title":"A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry","volume":"398","author":"Mehran","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcard.2026.134700_bb0135","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc17-1011","article-title":"Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis","volume":"40","author":"Nadkarni","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2026.134700_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110766","article-title":"Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: insight from SGLT2-I AMI PROTECT registry","volume":"202","author":"Paolisso","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ijcard.2026.134700_bb0145","article-title":"Reno-protective effects of SGLT2 inhibitors in patients with diabetes undergoing percutaneous coronary intervention: insights from the BMC2 registry","volume":"5","author":"Hyder","year":"2026","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134700_bb0150","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1038\/s41598-024-82991-7","article-title":"Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial","volume":"15","author":"Hosseini","year":"2025","journal-title":"Sci. Rep."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326005504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326005504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:30:13Z","timestamp":1787675413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326005504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"alternative-id":["S0167527326005504"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134700","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLIflozins in the prevention of contrast AssocIated NEphropathy: The GLICINE registry","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134700"}}